Shanbalaji Pharma Private Limited, a amalgamated private limited company, was established on 02 April 2018 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909TG2018PTC169180. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Employing 20 professional, Its leadership includes Narasaiah Arigela (Nominee Director), Selvakumar Shanmugham (Managing Director), Palepu Srinivasa Gopal (Nominee Director). Past directors included Narasaiah Arigela, Sarala Selvakumar. It holds no open charges and ₹9.00 Cr settled loans. Its latest AGM occurred on 16 August 2023, with the balance sheet filed on 31 March 2023. It is based at D. No, 7-2-1740, K.Subbaiah Pillai Godowns, Main Road, Sanath Nagar, Hyderabad, Hyderabad, Telangana, 500018.
U51909TG2018PTC169180
169180
02 April 2018
₹5.00 M
₹5.00 M
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Shanbalaji Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narasaiah Arigela | Nominee Director | 22 Aug 2022 | Current |
| Selvakumar Shanmugham | Managing Director | 01 Oct 2018 | Current |
| Palepu Srinivasa Gopal | Nominee Director | 29 Oct 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 13 Aug 2023 | Past |
| Pramod Abcsdd | Director | 03 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shanbalaji Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.65% increase. The company also saw a substantial improvement in profitability, with a 52.3% increase in profit. The company's net worth dipped by a decrease of 5.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Shanbalaji Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹90,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Nov 2018 | Hdfc Bank Limited | ₹9.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Shanbalaji Pharma has a workforce of 20 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shanbalaji Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shanbalaji Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shanbalaji Pharma Private Limited last Annual general meeting of members was held on 16 Aug 2023 as per latest MCA records. was recorded as a recent event.
Progress on A charge registered on 09 Nov 2018 via Charge ID 100223429 with Hdfc Bank Limited was fully satisfied on 04 Aug 2023. was documented.
Progress on Shanbalaji Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.
The activity A charge with Hdfc Bank Limited of Rs. 90.00 M registered on 09 Nov 2018 with Charge ID 100223429 was modified on 14 Nov 2022. was completed.
Narasaiah Arigela was appointed as a Nominee Director was appointed as a Nominee Director on 22 Aug 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.
The activity Palepu Srinivasa Gopal was appointed as a Nominee Director was appointed as a Nominee Director on 29 Oct 2019 & has been associated with this company since 6 years 1 month . was completed.
The CIN of Shanbalaji Pharma Private Limited is U51909TG2018PTC169180.
Shanbalaji Pharma Private Limited is headquartered at D. No, 7-2-1740, K.Subbaiah Pillai Godowns, Main Road, Sanath Nagar, Hyderabad, Hyderabad, Telangana, 500018.
Shanbalaji Pharma Private Limited was incorporated on 02 April 2018.
The current directors of Shanbalaji Pharma Private Limited are
The primary industry of Shanbalaji Pharma Private Limited is Trade.
Shanbalaji Pharma Private Limited is unlisted.
The authorized capital of Shanbalaji Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Shanbalaji Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX